Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–33.
Tabares-Guevara JH, Villa-Pulgarin JA, Hernandez JC. Atherosclerosis: immunopathogenesis and strategies for immunotherapy. Immunotherapy. 2021;13(14):1231–44.
Vallejo J, et al. Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq. Cardiovasc Res. 2021;117(13):2537–43.
Gupta M, et al. Novel emerging therapies in atherosclerosis targeting lipid metabolism. Expert Opin Investig Drugs. 2020;29(6):611–22.
Poznyak AV, et al. Anti-inflammatory therapy for atherosclerosis: focusing on cytokines. Int J Mol Sci. 2021;22(13):7061.
Li M, et al. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis. 2022;13(5):467.
He X, et al. Pyroptosis is a critical immune-inflammatory response involved in atherosclerosis. Pharmacol Res. 2021;165:105447.
Shan R, et al. Apoptosis, autophagy and atherosclerosis: relationships and the role of Hsp27. Pharmacol Res. 2021;166:105169.
Chen X, et al. Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation. Free Radic Res. 2021;55(4):405–15.
Zhao Y, et al. ROS-mediated programmed cell death (PCD) of Thalassiosira pseudonana under the stress of BDE-47. Environ Pollut. 2020;262:114342.
Wang L, et al. Oxidative stress in oocyte aging and female reproduction. J Cell Physiol. 2021;236(12):7966–83.
Castellini C, et al. Pathophysiology of mitochondrial dysfunction in human spermatozoa: focus on energetic metabolism, oxidative stress and apoptosis. Antioxidants (Basel). 2021;10(5):695.
Boz Z, et al. N-acetylcysteine prevents olanzapine-induced oxidative stress in mHypoA-59 hypothalamic neurons. Sci Rep. 2020;10(1):19185.
Sun H, et al. Harnessing C/N balance of Chromochloris zofingiensis to overcome the potential conflict in microalgal production. Commun Biol. 2020;3(1):186.
Prasad AS, Bao B. Molecular mechanisms of zinc as a pro-antioxidant mediator: clinical therapeutic implications. Antioxidants (Basel). 2019;8(6):164.
Blanter M, Gouwy M, Struyf S. Studying neutrophil function in vitro: cell models and environmental factors. J Inflamm Res. 2021;14:141–62.
Sharma A, et al. Modulation of Nrf2 by quercetin in doxorubicin-treated rats. Heliyon. 2020;6(4):e03803.
Lee DY, Song MY, and Kim EH. Role of oxidative stress and Nrf2/KEAP1 signaling in colorectal cancer: mechanisms and therapeutic perspectives with phytochemicals. Antioxidants (Basel). 2021;10(5):743.
Franco R, Navarro G, and Martínez-Pinilla E. Antioxidant defense mechanisms in erythrocytes and in the central nervous system. Antioxidants (Basel). 2019;8(2):46.
Li H, et al. Nrf2 deficiency attenuates atherosclerosis by reducing LOX-1-mediated proliferation and migration of vascular smooth muscle cells. Atherosclerosis. 2022;347:1–16.
Ying Z, et al. Lipoicmethylenedioxyphenol reduces experimental atherosclerosis through activation of Nrf2 signaling. PLoS ONE. 2016;11(2):e0148305.
Chen Y, et al. A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis. Redox Biol. 2020;32:101485.
Qiao Q, et al. Roles of dietary bioactive peptides in redox balance and metabolic disorders. Oxid Med Cell Longev. 2021;2021:5582245.
Li D, et al. The role of Nrf2 in hearing loss. Front Pharmacol. 2021;12:620921.
Ghanim BY, Qinna NA. Nrf2/ARE axis signalling in hepatocyte cellular death. Mol Biol Rep. 2022;49:4039–53.
Yu X, Li Y, Mu X. Effect of quercetin on PC12 Alzheimer’s disease cell model induced by Aβ (25–35) and its mechanism based on sirtuin1/Nrf2/HO-1 pathway. Biomed Res Int. 2020;2020:8210578.
Zhang Q, et al. Activation of Nrf2/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res. 2021;34:43–63.
Wang Y, et al. Circular RNAs: novel players in the oxidative stress-mediated pathologies, biomarkers, and therapeutic targets. Oxid Med Cell Longev. 2021;2021:6634601.
Song L, et al. Chinese herbal medicines and active metabolites: potential antioxidant treatments for atherosclerosis. Front Pharmacol. 2021;12:675999.
Buchmann GK, et al. Deletion of NoxO1 limits atherosclerosis development in female mice. Redox Biol. 2020;37:101713.
Trum M, Riechel J, and Wagner S. Cardioprotection by SGLT2 inhibitors-does it all come down to Na(+)? Int J Mol Sci. 2021;22(15):7976.
Trum M, et al. Inhibition of cardiac potassium currents by oxidation-activated protein kinase A contributes to early afterdepolarizations in the heart. Am J Physiol Heart Circ Physiol. 2020;319(6):H1347-h1357.
Matilla AJ. Cellular oxidative stress in programmed cell death: focusing on chloroplastic (1)O(2) and mitochondrial cytochrome-c release. J Plant Res. 2021;134(2):179–94.
Obeng E. Apoptosis (programmed cell death) and its signals - a review. Braz J Biol. 2021;81(4):1133–43.
Goldblatt ZE, Cirka HA, Billiar KL. Mechanical regulation of apoptosis in the cardiovascular system. Ann Biomed Eng. 2021;49(1):75–97.
Dou Z, et al. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation. J Exp Clin Cancer Res. 2021;40(1):194.
Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417.
Cheng Q, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
Li Q, et al. HRD1 prevents atherosclerosis-mediated endothelial cell apoptosis by promoting LOX-1 degradation. Cell Cycle. 2020;19(12):1466–77.
Zhang N, et al. The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis. Atherosclerosis. 2021;334:39–47.
Tawakol A, Abohashem S, Zureigat H. Imaging apoptosis in atherosclerosis: from cell death, a ray of light. J Am Coll Cardiol. 2020;76(16):1875–7.
Liu C, et al. The function, regulation and mechanism of programmed cell death of macrophages in atherosclerosis. Front Cell Dev Biol. 2021;9:809516.
Lin X, et al. Focus on ferroptosis, pyroptosis, apoptosis and autophagy of vascular endothelial cells to the strategic targets for the treatment of atherosclerosis. Arch Biochem Biophys. 2022;715:109098.
Fang S, et al. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1(+/-) mice display increases atherosclerotic plaque stability. Theranostics. 2021;11(19):9358–75.
Guo Y, et al. PCSK9 (proprotein convertase subtilisin/Kexin type 9) Triggers vascular smooth muscle cell senescence and apoptosis: implication of its direct role in degenerative vascular disease. Arterioscler Thromb Vasc Biol. 2022;42(1):67–86.
van der Meer IM, et al. Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis. The Rotterdam Coronary Calcification Study. Atherosclerosis. 2006;189(2):464–9.
Zadelaar AS, et al. Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer. Atherosclerosis. 2005;183(2):244–50.
Patel M, et al. Considerations for analysis of endothelial shear stress and strain in FSI models of atherosclerosis. J Biomech. 2021;128:110720.
Schneider DB, et al. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol. 2000;20(2):298–308.
Pi S, et al. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. Autophagy. 2021;17(4):980–1000.
留言 (0)